PROGRAMME OVERVIEW
www.wcpd2021.com
WEDNESDAY 22 ND SEPTEMBER DETAILED PROGRAMME
Laser Course
Date: Wednesday 22nd
Time: 08:55 – 13:15
Location: Breakout 1
Breakout 1 08:55 – 09:00 Welcome & Introduction
Dr Samira Batul (UK)
09:00 – 09:30 Dermatology Lasers – Basic Science & Training Requirements Dr Graham Bisset (UK)
09:30 – 10:00 Laser complications: when things go wrong Dr Firas al-Niami
10:00 – 10:30 Management of scars with lasers Dr Declan Collins (UK)
10:30 – 11:00 Setting up a laser unit (NHS/Private) Dr Bisola Laguda (UK)
11:00 – 11:15 EXHIBITION & POSTERS 11:15 – 11:30 Free paper
Dr Giulia Rinaldi
11:30 – 12:00 Laser applications for skin of colour Dr Zambia Kader (UK)
12:00 – 12:30 Laser applications for vitiligo and Acne Dr Faisal Ali (UK)
12:30 – 13:00 Psychology support for children undergoing laser therapy Dr Alice Childs (UK)
13:00 – 13:15 Open Discussion with Speakers
Paediatric Dermatology Course
Date: Wednesday 22nd
Time: 09:30 – 12:30
Location: Breakout 2
Breakout 2 09:00 - 09:05 Welcome & Introduction
Dr Karolina Gholam (UK) 09:05 - 09:20 Neonatal Rashes
Dr Gabriela Petrof (UK) 09:20 - 09:35 Infantile Haemangiomas
Dr Lea Solman (UK) 09:35 - 09:50 Bacterial & Viral Eruption
Dr Natalia Cartledge (UK) 09:50 - 10:05 Overview of Atopic Eczema
Dr Tess McPherson (UK) 10:05 - 10:20 Vascular Malformations
Dr Mary Glover (UK)
10:20 - 10:35 Common Blistering Disorders Prof Jemima Mellerio
10:35 - 10:50 Genital rashes
Dr Karolina Gholam (UK) 10:50 - 11:05 Fungal Infections
TBC
11:05 - 11:30 EXHIBITION & POSTERS 11:30 - 11:45 Dermatological Emergencies
Dr Paula Beattie (UK) 11:45 - 12:00 Overview of Birthmarks
Dr Maanasa Polubothu (UK) 12:00 - 12:15 COVID related eruptions
TBC 12:15 - 12:30 QUIZ
Dr Karolina Gholam (UK)
International Eczema Council Symposium
Founded in late 2014, the International Eczema Council (IEC) is a global nonprofit organization led by dermatology experts on atopic dermatitis. The IEC is dedicated to increasing the understanding of atopic dermatitis and promoting its optimal management through research, education, and patient/family care. Consistent with the organization’s charitable and educational objectives, the IEC is playing an increasing role as an important advisor to pharma, supporting negotiations with regulatory authorities and encouraging the use of new therapeutics that have been shown to be effective and safe.
Date: Wednesday 22nd
Time: 11:45 – 13:15
Location: Plenary Room
Topic: Management of Pediatric Atopic Dermatitis: A Global Perspective Plenary Room
11:45 – 12:00
Welcome & history of ISPD and IEC | Update on unmet needs & goals to bring
education worldwide; Setting the scene to the pediatric AD symposium & introduction of the Symposium Panel
Prof Amy Paller (US) Prof Carsten Flohr (UK)
12:00 – 12:10 Setting the scene for what’s new in therapy? A brief overview of the management of pediatric AD
Prof Mark Cork (UK)
Each 10-minute presentation below will be followed by 10 min of moderated discussions with the Panel
Panel discussion moderators:
Prof Amy Paller (US) Prof Carsten Flohr (UK)
Panelists:
Dr Helen Alexander (UK) Dr Valeria Aoki (Brazil)
Prof Mike Cork (UK) Prof Sandipan Dhar (India) Dr Carol Hlela (South Africa)
Prof Mark Koh (Singapore) 12:10 – 12:30 Atopic Dermatitis in Skin of Color
Dr Carol Hlela (South Africa)
12:30 – 12:55 The Role of the Microbiome & Skin Infections in Atopic Dermatitis Dr Helen Alexander (UK)
12:55 – 13:15 The Importance of Patient Education and Strategies for Delivery – A Global Perspective Dr Valeria Aoki (Brazil)
13:15 Closing Remarks Prof Amy Paller (US) Prof Carsten Flohr (UK)
International Society for Pediatric Dermatology Session
The International Society of Pediatric Dermatology (ISPD) is a worldwide, non-profit, scientific organization formed by professionals interested in promoting Pediatric Dermatology. It is aimed to carry out collaborative efforts to improve Pediatric Dermatology for the general health of infants and adolescents. Further aims include promotion of human and scientific relations with other scientific groups and societies having goals similar to those of the ISPD, as well as the formation of national societies of Pediatric Dermatology. The ISPD promotes the development of Pediatric Dermatology through clinical practice, research, teaching, conferences, courses, meetings, publications and consultation.
Date: Wednesday 22nd
Time: 13:45 – 15:15
Location: Plenary Room
Controversies in Pediatric Dermatology
Breakout 1 13:30 – 13:45 Welcome and Introduction
Prof Amy Paller, ISPD President (US)
13:45 – 14:20
To treat or not to treat?
Moderated by Prof Amy Paller (US)
Scenario #1: Alopecia areata Dr Eulalia Baselga (Spain) Prof Sandipan Dhar (India) Dr Ellis Hon (Hong Kong)
Prof Margarita Larralde (Argentina) Dr Arti Nanda (Kuwait)
Dr Andrea Zaenglein (US) Dr Kelvin Mponda (Malawi) Scenario #2: Molluscum
Scenario #3: Methotrexate to treat moderate-to-severe psoriasis
14:20 – 14:55
Technology: Its value vs its cost?
Moderated by Dr Arti Nanda (Kuwait)
Scenario #1: Artificial Intelligence Prof Christine Bodemer (France) Dr Mark Koh (Singapore) Dr Amy Paller (US)
Prof Eli Sprecher (Israel) Dr Gail Todd (South Africa) Scenario #2: Teledermatology
Scenario #3: New age techniques/
technology in the area of pediatric dermatology
14:55 – 15:00 Closing Prof Amy Paller (US)
British Society for Paediatric Dermatology Session
The British Society for Paediatric Dermatology (BSPD) is an affiliated group of the British Association of Dermatologists and is the only organisation in the UK and Ireland specifically dedicated to Paediatric Dermatology.
The Society exists to promote further understanding of skin disease in children and to enhance their care by encouraging education and research in all aspects of paediatric dermatology. As a part of this role, the BSPD holds meetings three times a year, one at the annual conferences of the British Association of Dermatologists, one at the Royal College of Paediatrics and Child Health and has its own Annual Scientific Meeting.
The BSPD membership includes consultant and trainee dermatologists and paediatricians, geneticists and members of other medical specialties involved in the care of children with skin disease
Date: Wednesday 22nd Time: 15:20 – 17:00
Location: Plenary Room
Looking Beyond Paediatric Dermatology
Plenary Room 15:20 – 15:30 Welcome & Introduction
Prof Carsten Flohr (UK) & Dr Tess McPherson (UK) 15:30 – 15:40 In Memory of Olivia Schofield
Prof Pamela McHenry (UK)
15:40 – 16:05 Human Factors in Paediatric Dermatology Prof Celia Moss (UK)
16:05 – 16:30 On The Philosophy of Disease Diagnosis Prof Hywel Williams (UK)
16:30 – 17:00 Why Do Research?
Prof Sara Brown (UK)
Plenary Room 17:00 – 17:30
Keynote Lecture 1:
Prof Amy Paller (US)
Pathogenesis-based Therapy for Congenital Ichthyoses and Ichthyosiform Disorders: Beyond the Gene
Chairs: Dr Paula Luna (Argentina) & Dr Arti Nanda (Kuwait)
Breakout Room 1
17:45 – 18:30 Bristol Myers Squibb
Gold Sponsored Symposium
THURSDAY 23 RD SEPTEMBER DETAILED PROGRAMME
Day 2 | THURSDAY 23
rdSEPTEMBER 07:30 – 18:45
Plenary Room Breakout 1 Breakout 2
07:30 – 08:15 Silver Sponsored Symposium CERAVE
08:15 – 08:45 EXHIBITION & POSTERS
09:00 – 11:00
Session 1: Allergy, Contact Dermatitis & Urticaria Chairs: Dr Natalia Cartledge (UK) & Dr Carina Venter (US)
Session 2: Skin Imaging & Pathology Chairs: Dr Sylvie Fraitag (France) &
Dr Josep Malvehy (Spain)
Session 3: Infections &
Infestations
Chairs:Assoc Prof Marie Victoria Dizon (Philippines) &
Dr Anthony Mancini (US) 09:00 – 09:20 TBC
TBC
Surveillance imaging in paediatric melanoma
Dr Alberto Pappo (US)
All the Latest About Scabies Dr Prof Franck Boralevi (France)
09:20 – 09:40 The Future of Food Allergy Management
Prof Adam Fox (UK)
Image-Based Monitoring of Pigmentary Lesions
Dr Ashfaq Marghoob (US)
Paediatric Syphilis Dr Jon Dyer (US) 09:40 – 10:00
Elimination diets for eczema: benefits and risks
Dr Carina Venter (US)
Dermoscopy for Paediatric Dermatologists
Dr Josep Malvehy (Spain)
Interesting Cases in Cutaneous Infections Dr Maria Trinidad-Hasbun (Chile)
10:00 – 10:10
Allergic contact
dermatitis: New emerging allergens
Dr Antti Lauerma (Finland)
Dermpath of Vascular Anomalies Dr Isabel Colmenero (Spain)
Bugs and infestation issues in Asia
Assoc Prof Marie
Victoria Dizon (Philippines) 10:10 –
10:20 Novel Therapies Urticaria Dr Tabi Leslie (UK)
Neonatal life-threatening diseases:
usefulness of cutaneous biopsy Dr Sylvie Fraitag (France)
Chikungunya : Profile of skin lesions in the Pediatric age group
Dr Arun Inamadar (India)
10:20 – 10:30
The classification of topical corticosteroids:
chaos in need of harmony
Dr Diana Purvis (New Zealand)
Useful (Histological) Clues in Assessing Blistering Disorders Dr Saleem Taibjee (UK)
Infections and Infestations in Ethiopia at a Glance
Dr Messay Tesfaye (Ethiopia)
10:30 – 10:40
Submitted Abstract SP01 Bier anaemic spots, cyanosis, and urticaria-like eruption (BASCULE)
syndrome: A case series of 4 patients
Dr Rachel Fisher (UK)
Submitted Abstract
SP03 Optimisation of sampling for a new skin microbiome assay pilot study
Dr Anita Smith (Australia)
Submitted Abstract SP05 Childhood Leprosy - A rarity or a regularity?
A clinico-epidemiological study from an endemic area Dr Sahana P Raju (India)
10:40 – 10:50
Submitted Abstract SP02 Investigating
associations between the infant skin microbiome, environmental factors and atopic eczema, using a population-based birth cohort
Dr Conor Broderick (UK)
Submitted Abstract
SP04 Recognising Bone Marrow Oedema Syndrome (BMOS) in a Paediatric Dermatology Clinic Dr Georgina Juniper Australia)
Submitted Abstract SP06 Mucosal erythema multiforme in paediatric patients diagnosed with COVID-19: a case series Dr Stephanie Bowe (Ireland)
11:00 – 11:45 Exhibition & Posters 11:45 – 12:15
Keynote Lecture 2:
Prof Gil Yosipovitch (US)
Systemic Causes and Mangement of Itch in the Pediatric Population – An Unexplored Area
Chairs: Prof Franck Boralevi (France) & Dr Dawn Siegel (US) 12:15 – 12:45
Keynote Lecture 3:
Prof Veronica Kinsler (UK) Advances in Mosaicism
Chairs: Dr Beth Drolet (US) & Dr Antonio Torrelo (Spain) 13:00 – 13:45 Gold Sponsored SymposiumMUSTELA
PAMPERS
Gold Sponsored Symposium 14:00 – 16:00
Session 4: Atopic Dermatitis
Chairs:Prof Alan Irvine (Ireland) & Dr Debra Lomas (UK)
Session 5: Immune & Connective Tissue Diseases
Chairs: Prof Bert Callewaert (Belgium) & Dr Lisa Weibel (Switzerland)
Session 6: Mucosal, Hair & Nail Diseases
Chairs: Prof Sandiphan Dhar India) & Prof Dedee Murrell (Australia)
14:00 – 14:20 Epidemiology of AD Prof Sebastian Barbarot (France)
Autoimmune Skin Manifestations and Immunodeficiencies
Dr Arti Nanda (Kuwait)
Novel genes for hypotrichosis simplex – what do they implicate?
Prof. Dr. Regina Betz (Germany)
14:20 – 14:40 Systemic treatments
Prof Carsten Flohr (UK) Autoinflammatory
Dr Antonio Torrelo (Spain)
How to make an accurate diagnosis in paediatric hair disorders
Dr Paul Farrant (UK) 14:40 – 15:00
Proteolytic and anti- proteolytic activity in skin diseases: gluing the pieces together
Prof Eli Sprecher (Israel)
Localised Scleroderma Dr Lisa Weibel (Switzerland)
Paediatric Autoimmune Blistering Diseases
Prof Dedee Murell (Australia)
15:00 – 15-10
The role of the microbiome in AD Prof Stephanie Christen- Zäch (Switzerland)
A Clinically Oriented Classification of Cutis Laxa Syndromes
Prof Bert Callawaert (Belgium)
The Mouth of Newborns Dr Mario Cutrone (Italy)
15:10 – 15:20
Atopic Dermatitis in Skin of Colour
Prof Sandipan Dhar (India)
Graft versus host disease: Top 10 things a pediatric dermatologist should know
Dr Jennifer Huang (US)
Treatment of Alopecia Areata
Prof. Dr. Miloš Nikolić (Serbia) 15:20 – 15:30 Education in AD
Dr Leong Kin Fon (Malaysia)
Cryopyrin- associated diseases Prof Kieron Leslie (US)
Common Pediatric Nail Disorders
Prof Archana Singal (India)
15:30 – 15:40
Submitted Abstract SP07 Evidence based medicine or evidence based marketing? An assessment of the early publication profiles of crisaborole and dupilumab
Dr Lloyd Steele (UK)
Use of IVIG in Children Prof. Dr. Beatrix Volc-Platzer (Austria)
Submitted Abstract
SP11 Longer-term safety and efficacy of tofacitinib in adolescents with alopecia areata: a retrospective, single centre study
Dr Rebekka Jerjen (Australia)
15:40 – 15:50
Submitted Abstract SP08 Adverse Events and Treatment Failure among
Submitted Abstract
SP09 Two-year efficacy and safety profile
Submitted Abstract
Children on Dupilumab for Atopic Dermatitis at an Urban Tertiary
Care Center
Dr Paige McKenzie (US)
of secukinumab in pediatric patients with severe chronic plaque psoriasis Prof Dorota Krasowska
SP12 Genetic Hair Shaft disorders: clinical study of 115 cases
Dr Sahana Srinivas (India)
15:50 – 16:00
Submitted Abstract
SP10Prevalence, pattern and factors affecting skin diseases among children with human immunodeficiency virus (HIV) infection
Dr Aisha Yahya (Nigeria)
16:00 – 16:45 Exhibition & Posters
16:45 – 17:15
Keynote Lecture 4:
Prof Inderjeet Dokal (UK)
Dyskeratosis congenital and related diseases
Chairs: Prof. Dr. Peter Höger (Germany) & Prof Alain Taïeb (France) 17:15 – 17:45
Keynote Lecture 5:
Alan Irvine (Ireland) Title TBC
Chairs: Dr Paula Beattie (UK) & Prof Larry Eichenfield (US)
FRIDAY 24 TH SEPTEMBER DETAILED PROGRAMME
Day 3 | FRIDAY 24
thSEPTEMBER 08:00 – 19:00
Plenary Room Breakout 1 Breakout 2
08:00 – 08:45 SKIN HEALTH ALLIANCE & WATERWIPES
Silver Sponsored Symposium SANOFI
Silver Sponsored Symposium 09:00 – 11:00
Session 7: Adolescent Dermatology
Chairs:Dr David Atherton (UK) & Dr Tess McPherson
Session 8: Ichthyosis & Ectodermal Dysplasia
Chairs:Dr Angela Hernandez-Martin (Spain) & Prof. Dr. Peter Steijlen (the Netherlands)
Session 9: Vascular Malformations
Chairs:Dr Eulalia Baselga- Torres (Spain)
09:00 – 09:20 Female Genital Mutilation Dr Brenda Kelly (UK)
Congenital ichthyosis: lessons learnt from a multidisciplinary clinic
Dr Angela Hernandez-Martin (Spain)
Emergencies in Vascular Malformations
Dr Eulalia Baselga-Torres (Spain)
09:20 – 09:40 Skin Stigma and Services Dr Tess McPherson (UK)
Therapies for Icthyosis - What Works and What's New
Dr Juliette Mazereeuw-Hautier (France)
Vascular stains: Moving beyond “nevus flammeus”,
“port-wine stains”, and
“capillary malformations”
Prof Ilona Frieden (US) 09:40 – 10:00 Hormonal Treatment of
Acne in Adolescents Dr Andrea Zaenglein (US)
Care of the Neonate with Ichthyosis Prof Jemima Mellerio (UK)
Management of Vascular Tumours
Dr Lea Solman (UK) 10:00 – 10:10
Management of
Adolescent Transgender Skin
Dr Lucía Campos-Muñoz (Spain)
Hereditary muco-epithelial dysplasia and IFAP syndrome - disorders of the SREBP pathway
Dr Fanny Morice-Picard (France)
Generalised Lymphatic Anomaly
Dr Mary Glover (UK)
10:10 – 10:20
Public Exhibition of Naevi Improves Self- Image
Dr Jodi Whitehouse (UK)
TITLE TBC
Dr Vincenz Oji (Germany)
Factors
Complicating Hemangioma Treatment with Beta-
Blockers
Dr Rod Phillips (Australia) 10:20 – 10:30 Sleep in adolescents
Dr Michael Farquhar (UK)
Experiences of a 20 Year Ichthyosis Service
Prof. Dr. Peter Steijlen (the Netherlands)
Latest Advances in
Arteriovenous Malformations Dr Maanasa Polubothu (UK)
10:30 – 10:40
Submitted Abstract SP13 A summary of messages for healthcare professionals from adolescents with skin disease
Dr Isabella de Vere Hunt (UK)
Submitted Abstract
SP15 A 2‐year incidence study of severe congenital ichthyosis in the U.K. and Ireland
Prof Celia Moss (UK)
Submitted Abstract
SP17 Aberrant activation of calcium signalling is induced by GNA11 and GNAQ mutations and is reversed by targeted genetic therapy in vitro
Dr Davide Zecchin (UK)
10:40 – 10:50
Submitted Abstract SP14 Depression screening for patients aged 12-17 receiving oral isotretinoin for acne vulgaris
Dr Blanca Estupinan (US)
Submitted Abstract
SP16 Utility of palmar hyperlinearity as a clinical sign to predict FLG null genotype
Dr Sara Brown (UK)
Submitted Abstract SP18 HEK-Tufted Angioma.
Clinical experience and follow up in a tertiary institution.
Dr Natalia Torres (Argentina)
11:00 – 11:45 Exhibition & Posters 11:45 – 12:15
Keynote Lecture 6:
Prof Danya Glaser (UK)
The Relevance of Fabricated or Induced Illness (FII)to Paediatric Dermatology
Chairs: Dr Tor Shwayder (US) & Dr Dirk van Gysel (Belgium) 12:15 – 12:45
Keynote Lecture 7:
Prof Virginia Sybert (US)
Lessons Learned About Genodermatoses – The Hard Way Prof Veronica Kinsler (UK) & Prof John McGrath (UK) 13:00 – 14:00 Platinum Sponsored SymposiumSANOFI
14:00 – 16:00
Session 10: Mosaic Disorders
Chairs: Dr Harper Price (US) & Prof
Pierre Vabres (France)
Session 11: Epidermolysis Bullosa Chairs: Dr Christina Has
(Germany) & Dr Irene Lara Corrales (Canada)
Session 12: Advances in Therapeutics
Chairs: Dr Mark Koh (Singapore) & Prof Amy Paller (US) 14:00 – 14:20
Advances in Proteus Syndrome
Dr Leslie Biesecker (US)
Latest classification of EB Dr Cristina Has (Germany)
14:20 – 14:40
Understanding Congenital haemangiomas Dr Keith Choate (US)
Research Update Prof John McGrath (UK)
Repurposing of Therapies in Paediatric
Dermatology Dr James Treat (US) 14:40 – 15:00
PHACE Beyond Infancy:
What Do We Need to Watch?
Dr Dawn Siegel (US)
Renal disease in EB Dr Agnes Schwieger-Briel (Switzerland)
Acne - Pathogenesis Based Treatment
Prof Maurice van Steensel (Singapore)
15:00 – 15:10
Patient Pathway in Mosaic Disorders Dr Andrea Diociaiuti (Italy)
4 stages of EB and an update on MissionEB
Dr Anna Martinez (UK)
Therapy for Conradi- Hunnermann
Dr Antoni Gostynski (the Netherlands)
15:10 – 15:20
Unsolved Mosaic Phenotypes
Prof Rudolph Happle (Germany)
Severe forms of EB are systemic disorders: Anemia as a Paradigm Dr Anna Bruckner (US)
Biologics in Psoriasis Dr Karolina Gholam (UK)
15:20 – 15:30
Mouse models for mosaic skin conditions Prof Lionel Larue (France)
Epidermiology of inherited EB in the UK
Dr Gabriela Petrof (UK)
Adverse Drug Reactions in Paediatric Dermatology Dr Mark Koh (Singapore)
15:30 – 15:40
Submitted Abstract SP19Genetic
and lipidomic characteris ation of ILVEN identifies a role for cholesterol in the biology and treatment of disease
Dr Melissa Riachi (UK)
Submitted Abstract
SP21Genotype-phenotype
correlation of epidermolysis bullosa (EB) with pyloric atresia: data from the UK EB database
Dr Gabriela Petrof (UK)
Submitted Abstract SP23 Cutaneous adverse events to targeted therapies and immunotherapies in children; a retrospective study of 103 patients from two tertiary Hemato- Oncology referral centers Dr Ayelet Ollech (Israel) 15:40 – 15:50 Submitted Abstract Submitted Abstract Submitted Abstract
SP20Multiple papules on the face of a patient with congenital hypertrichosis Dr Aniza Giacaman (Spain)
SP22Assessing pain catastrophizing and functional disability
in pediatric epidermolysis bullosa patients and their caregivers Dr Sneha Rangu
SP24 Long-Term Efficacy and Safety Data for Dupilumab in a Phase 3, Open-Label Extension Trial (LIBERTY AD PED-OLE) in Patients Aged ≥ 6 to < 12
Years With Uncontrolled, Moderate-to-Severe Atopic Dermatitis (AD)
Prok Mike Cork (UK)
16:00 – 17:00 Exhibition & Posters
17:00 – 17:30
Keynote Lecture 8:
Prof Pierre Vabres (France) I Walk the Line
Chairs: Dr Jon Dyer (US) & Dr Mary Glover (UK) 17:30 – 18:00
Keynote Lecture 9:
Prof Kelly Cordoro (US)
Pediatric Psoriasis: Management Challenges and Opportunities Chairs: Prof Lone Skov (Denmark) & Prof Eli Sprecher (Israel)
18:15 – 19:00 PIERRE FABRE
Gold Sponsored Symposium
SATURDAY 25 th SEPTEMBER DETAILED PROGRAMME
Day 4 | SATURDAY 25
thSEPTEMBER 08:00 – 14:00
Plenary Room Breakout 1 Breakout 2
08:00 – 08:45 AMRYT PHARMA
Gold Sponsored Symposium LA ROCHE POSAY Gold Sponsored Symposium 09:00 – 11:00
Session 13: Mixed Chairs:Prof
Christine Bodemer (France) & Prof Rashmi Sarkar (India)
Session 14: Skin Tumours & Infiltrations Chairs: Prof Margarita Larralde (Argentina) & Dr Elene Pope (Canada)
Session15: Pigmentary Disorders
Chairs: Dr Mauro Picardo (Italy) &
Dr Julie Schaffer (US)
09:00 – 09:20
Viruses, vaccines, and vulnerabilities; Three pandemic-related discoveries that will change pediatric dermat ology
Dr Beth Drolet (US)
Mastocytosis
Prof Christine Bodemer (France)
Latest Developments in Vitiligo
Dr Mauro Picardo (Italy)
09:20 – 09:40 Update on Neonatal Skin Prof. Dr. Peter Höger (Germany)
Dermatologic aspects of Langerhans Cell Histiocytosis
Dr Paula Luna (Argentina)
BAP1 Tumour Predisposition Syndrome
Mr Sebastian Walpole (Australia)
09:40 – 10:00
Reactive
Infectious Mucocutaneou s Eruptions
Prof Albert Yan (US)
Lymphoma in Paediatric Dermatology
Dr Elena Pope (Canada)
The Genetics of Spitz Naevi Dr Iwei Yeh (US)
10:00 – 10:10
Risk factors for eczema herpeticum Dr Sherief Janmohamed (Belgium)
Molluscum Contagiosum - to treat or not to treat
Prof. Dr. Hab. Wojciech Baran (Poland)
Melanocytic Nail Disorders in Children
Dr Luc Thomas France)
10:10 – 10:20
Autoimmune blistering diseases in pregnancy – is there a risk for a baby?
Dr Branka Marinovic (Croatia)
Non-Vascular Tumours of Infancy Prof Margarita Larralde (Argentina)
Greying Hair Syndromes Dr Carola Duran-McKinster (Mexico)
10:20 – 10:30
The face of atopic dermatitis in South Africa Prof Carola Hlela (South Africa)
Skin Lesions:
When is it a Sign of a Serious Disease Dr Donna Marie Sarrosa (Philippines)
Atypical Naevus Syndrome Prof. Dr. Harald Kittler (Austria)
10:30 – 10:40
Submitted Abstract SP25 Hidradenitis suppurat iva in adolescents: a case series
Dr Joan Garcias Ladaria (Spain)
Submitted Abstract SP29 Nail matrix nevi in children: a prospective study
Dr Christina Stefanaki (Greece)
10:40 – 10:50
Submitted Abstract SP26 Atypical borrelial lym phocytoma in children: a
Submitted Abstract
SP28 Cutaneous manifestations associated with paediatric
Submitted Abstract
SP30 Childhood Vitiligo and associated disorders
including autoimmune
diagnosis not to be missed
Dr Isabelle Luchsinger (Switzerland)
malignancies: a cross-sectional study of 108 patients
Dr Akash Agarwal (India)
diseases: A prospective study
Dr Mrinal Gupta (India)
11:00 – 12:45 Exhibition & Posters
12:45 – 13:15
Keynote Lecture 10:
Prof Christine Labrèze (France)
Beta-blockers for Infantile Haemangiomas: Successes and Failures Chairs: Prof Ilona Frieden (US) & Dr Lea Solman (UK)
13:15 – 13:45
Keynote Lecture 11:
Prof Michele de Luca (Italy) Title TBC
Chairs: Dr Marieke Bolling the Netherlands) & Dr Anna Martinez (UK)
13:45 – 14:00 Closing Remarks
Awards, Prizes & WCPD2025
